Cardiac Vascular News

Coronary/Structural Heart

Neovasc Wins German Court Appeal; Announces German Court’s Decision to Dismiss CardiAQ’s Claim to Co-inventorship of a European Patent for Tiara™

March 21, 2019 0 comments

VANCOUVER, March 21, 2019 /PRNewswire/ – Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ: NVCN)(TSX: NVCN), a leader in the development of minimally invasive transcatheter mitral valve replacement technologies and in the development of minimally invasive devices for the treatment of refractory angina, today announced that the Higher Regional Court in Munich, Germany, on appeal […]

Zenosense, Inc.: Update on MIDS Medical Test Strip Development

March 20, 2019 0 comments

VALENCIA, SPAIN, March 20, 2019 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Zenosense, Inc. (OTCQB: ZENO, “Zenosense”, the “Company”), a healthcare technology company focused on the development and commercialization of the MIDS Cardiac™ hand-held technology for the early detection of heart attack at the Point of Care, is pleased to announce an […]

Itamar Medical Advances Simple, Accurate and Reliable Home Sleep Apnea Testing with Launch of WatchPAT™ 300

March 20, 2019 0 comments

CAESAREA, Israel, March 20, 2019 (GLOBE NEWSWIRE) — Itamar Medical Ltd. (Nasdaq & TASE: ITMR), a company that develops, manufactures and markets non-invasive diagnostic medical devices for sleep apnea with a focus on the cardiology market, today announced the launch of WatchPAT 300, the next generation WatchPAT system for home sleep […]

Interviews/Contributions

Audio: Hakon Bergheim, COO of Adagio Medical speaks with CardiacVascularNews

March 8, 2019 0 comments

Audio recording: Hakon Bergheim, COO of Adagio Medical speaks with CardiacVascularNews

Other News

Endologix Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Financial March 21, 2019 by Ken Dropiewski 0 comments

RVINE, Calif.–(BUSINESS WIRE)–Endologix, Inc. (Nasdaq:ELGX) (the “Company”), a developer and marketer of innovative treatments for aortic disorders, announced today the grant of inducement equity awards to nine newly hired employees (the “Awardees”). The awards were approved by the Company’s Compensation Committee, which is comprised of independent Directors, on March 13, 2019, as […]

Continue Reading →

FDA approves new device for treating moderate to severe chronic heart failure in patients

Regulatory Rhythm March 21, 2019 by Ken Dropiewski 0 comments

SILVER SPRING, Md., March 21, 2019 /PRNewswire/ — The U.S. Food and Drug Administration today approved the Optimizer Smart system for treating patients with chronic, moderate-to-severe heart failure who are not suited for treatment with other heart failure devices such as cardiac resynchronization therapy to restore a normal timing pattern of the heartbeat. […]

Continue Reading →

Vixiar Medical Raises $1.5 Million in Additional Financing

Financial March 20, 2019 by Ken Dropiewski 0 comments

BALTIMORE–(BUSINESS WIRE)–Vixiar Medical, Inc., a privately held Maryland company dedicated to the development of non-invasive devices and systems for monitoring cardiopulmonary diseases, announced today that it closed its most recent financing of $1.5 million from new and existing investors. Proceeds will be used to complete an ongoing clinical trial and […]

Continue Reading →

Zenosense, Inc.: Update on MIDS Medical Test Strip Development

Coronary/Structural Heart March 20, 2019 by Ken Dropiewski 0 comments

Continue Reading →

Endonovo Therapeutics Partners with SunMED Medical Systems

Peripheral/Endo March 20, 2019 by Ken Dropiewski 0 comments

LOS ANGELES, CA, March 20, 2019 (GLOBE NEWSWIRE) — Endonovo Therapeutics, Inc. (OTCQB: ENDV) (“Endonovo” or the “Company”), Alan Collier, Endonovo’s Chief Executive Officer, stated “We are pleased to announce our partnership with SunMED Medical Solutions (“SunMED”). SunMED is one of the premier medical equipment distributors and claims experts in the country. […]

Continue Reading →

Itamar Medical Advances Simple, Accurate and Reliable Home Sleep Apnea Testing with Launch of WatchPAT™ 300

Coronary/Structural Heart March 20, 2019 by Ken Dropiewski 0 comments

Continue Reading →

Correvio Announces Presentation Of Brinavess® Data At The American College Of Cardiology 2019 Annual Meeting

Rhythm March 20, 2019 by Ken Dropiewski 0 comments

VANCOUVER, March 20, 2019 /PRNewswire/ – Correvio Pharma Corp. (NASDAQ: CORV) (TSX: CORV), a specialty pharmaceutical company focused on commercializing hospital drugs, today announced the presentation of new Brinavess® (vernakalant hydrochloride, IV) data at the American College of Cardiology 2019 Annual Meeting taking place March 16-18, 2019, in New Orleans. This poster presentation highlights reduced […]

Continue Reading →

Rex Medical Completes Patient Enrollment for the REVEAL Peripheral Atherectomy U.S. Trial

Peripheral/Endo March 19, 2019 by Ken Dropiewski 0 comments

March 19, 2019 10:14 AM Eastern Daylight Time CONSHOHOCKEN, Pa.–(BUSINESS WIRE)–Rex Medical, L.P., a medical device design and development company, today announced the successful completion of enrollment in the Revolution™ Peripheral Atherectomy System for Lower Extremity Peripheral Arterial Revascularization (REVEAL) IDE clinical trial. The REVEAL trial is a single arm, […]

Continue Reading →

Hoag Clinical Trial Contributes to ‘Eye-Popping’ National Heart Surgery Data

Coronary/Structural Heart March 19, 2019 by Ken Dropiewski 0 comments

NEWPORT BEACH, Calif., March 18, 2019 /PRNewswire/ — The Jeffrey M. Carlton Heart & Vascular Institute at Hoag, the largest volume cardiovascular program in Orange County, was the first hospital to bring transcatheter aortic valve replacement (TAVR) to the community. Today, the American College of Cardiology (ACC) released data from two trials showing […]

Continue Reading →

Data from the Non-interventional EMIT-AF/VTE Study Shows Low Thromboembolic and Bleeding Event Rates in Unselected Elderly AF/VTE Patients on Oral, Once-daily LIXIANA®▼ Undergoing Diagnostic or Therapeutic Procedures

Peripheral/Endo Rhythm March 19, 2019 by Ken Dropiewski 0 comments

MUNICH, March 19, 2019 /PRNewswire/ — In 2019, the Edoxaban Clinical Research Programme will deliver new evidence on LIXIANA®▼ (edoxaban) use in clinical practice. EMIT-AF/VTE is one of the first sets of data to be presented EMIT-AF/VTE is a large observational, multicentre, multinational study on edoxaban peri-procedural management and outcomes It is […]

Continue Reading →

Featured

Neovasc Wins German Court Appeal; Announces German Court’s Decision to Dismiss CardiAQ’s Claim to Co-inventorship of a European Patent for Tiara™

Zenosense, Inc.: Update on MIDS Medical Test Strip Development

Endonovo Therapeutics Partners with SunMED Medical Systems

Rex Medical Completes Patient Enrollment for the REVEAL Peripheral Atherectomy U.S. Trial

Top Stories

Endologix Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

FDA approves new device for treating moderate to severe chronic heart failure in patients

Vixiar Medical Raises $1.5 Million in Additional Financing

Ra Medical Systems Reports 2018 Fourth Quarter and Full Year Financial Results

BioSig Technologies Completes Private Placement

FDA Approves Industry’s Smallest, Slimmest 3T Tachycardia Devices from BIOTRONIK

BD Receives U.S. FDA Approval for First Venous Stent to Treat Iliofemoral Venous Occlusive Disease

FDA approves new indication for valve repair device to treat certain heart failure patients with mitral regurgitation

ABBOTT RECEIVES FDA APPROVAL FOR EXPANDED INDICATION FOR MITRACLIP™ DEVICE

Tenaya Therapeutics Strengthens Leadership Team with Appointment of Two Biopharmaceutical Industry Veterans

Endonovo Therapeutics Partners with SunMED Medical Systems

Rex Medical Completes Patient Enrollment for the REVEAL Peripheral Atherectomy U.S. Trial

Data from the Non-interventional EMIT-AF/VTE Study Shows Low Thromboembolic and Bleeding Event Rates in Unselected Elderly AF/VTE Patients on Oral, Once-daily LIXIANA®▼ Undergoing Diagnostic or Therapeutic Procedures

Endologix Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Vixiar Medical Raises $1.5 Million in Additional Financing

Ra Medical Systems Reports 2018 Fourth Quarter and Full Year Financial Results

Recent

Endologix Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

FDA approves new device for treating moderate to severe chronic heart failure in patients

Neovasc Wins German Court Appeal; Announces German Court’s Decision to Dismiss CardiAQ’s Claim to Co-inventorship of a European Patent for Tiara™

Vixiar Medical Raises $1.5 Million in Additional Financing

Zenosense, Inc.: Update on MIDS Medical Test Strip Development

Endonovo Therapeutics Partners with SunMED Medical Systems

Itamar Medical Advances Simple, Accurate and Reliable Home Sleep Apnea Testing with Launch of WatchPAT™ 300

Quantum Genomics Announces Positive Results from New Preclinical Studies on Firibastat

Correvio Announces Presentation Of Brinavess® Data At The American College Of Cardiology 2019 Annual Meeting

Rex Medical Completes Patient Enrollment for the REVEAL Peripheral Atherectomy U.S. Trial

Other News

Recent

Popular

Subscribe to Blog via Email

Audio: Hakon Bergheim, COO of Adagio Medical speaks with CardiacVascularNews